Back to search

Article

The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenic

2019-06-26

Abstract excerpt

<h4>ABSTRACT</h4> Colorectal cancer (CRC) is a malignant cancer with high incidence and mortality in the world, as the result of the traditional treatments. Immunotherapy targeting neoantigens can induce durable tumor regression in cancer patients, but is almost limited to individual treatment, resulting from the unique neoantigens. Many shared oncogenic mutations are detected, but whether the common neoantigens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
616470a0-4f51-59b7-8393-b9da832ceb19
DOI
10.1101/682617
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenicDOI 10.1101/682617
Select a neighboring publication to make it the new centre.